Navigation Links
FDA Approves ACTOplus met(R) XR (pioglitazone HCl and metformin HCl extended-release) Tablets for the Treatment of Type 2 Diabetes
Date:5/13/2009

pioglitazone, metformin, or any other component of ACTOplus met and ACTOplus met XR. ACTOplus met and ACTOplus met XR should not be taken by people who drink excessive amounts of alcohol. ACTOplus met and ACTOplus met XR should be discontinued in patients with severe infection or in patients undergoing X-ray studies using intravenous contrast dye. Talk to your health professional before discontinuing any medications.

Your health professional should perform a blood test to check for liver problems before you start ACTOplus met and ACTOplus met XR and periodically thereafter. Do not take ACTOplus met and ACTOplus met XR if you have active liver disease. Talk to your doctor immediately if you experience nausea, vomiting, stomach pain, tiredness, loss of appetite, dark urine, or yellowing of the skin. If you are of childbearing age, talk to your doctor before taking ACTOplus met and ACTOplus met XR, as they could increase your chance of becoming pregnant. Some people, particularly women, are at higher risk of having bone fractures while taking ACTOplus met and ACTOplus met XR. Patients with diabetes should have regular eye exams. If you experience vision problems, consult your doctor immediately. Very rarely, some patients have experienced visual changes while taking pioglitazone, a component of ACTOplus met and ACTOplus met XR.

Safety and effectiveness of ACTOplus met and ACTOplus met XR in pediatric patients have not been established. Use in pediatric patients is not recommended for the treatment of diabetes due to lack of long-term safety data. ACTOplus met XR must be swallowed whole and not chewed, cut, or crushed.

There h
'/>"/>

SOURCE Takeda Pharmaceutical Company Limited
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. Treating Untreatable Brain Tumors: FDA Approves New Laser Surgery
2. FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets
3. Video: FDA approves Exforge HCT(R) - the Only High Blood Pressure Treatment to Combine Three Medications in a Single Pill
4. Kaiser Permanente Approves $13 Million in Community Benefit Grants in First Quarter of 2009
5. FDA Approves Plan B Pill for 17-Year-Olds
6. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
7. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
8. FDA Approves New Indication for Wyeths TYGACIL (tigecycline) for the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia
9. U.S. FDA Approves New THERAKOS(TM) CELLEX(TM) Photopheresis System
10. FDA Approves Symbyax(R) as First Medication for Treatment-Resistant Depression
11. FDA Approves Two Hologic HPV Tests
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... Men who show signs of chronic inflammation in non-cancerous ... actually having prostate cancer than those with no inflammation, ... researchers from the Johns Hopkins Kimmel Cancer Center. , ... stronger for men with so-called high-grade prostate cancer ... indicating the presence of the most aggressive and ...
(Date:4/17/2014)... the April issue of Experimental Biology and ... Drs. Rex Gaskins and Paul Kenis in the ... of the University of Illinois Urbana-Champaign describe their ... reactions underlie a variety of cell functions including ... these crucial roles in regulating normal cellular behavior, ...
(Date:4/17/2014)... biology team has created a new technology for ... could travel the body and selectively target cancer ... biological devices that monitor and modify human physiology ... However, no existing technology enabled bioengineers to build ... and respond in a customized fashion. , "The ...
(Date:4/17/2014)... April 17, 2014-- Colic affects about one in five ... numerous pediatric visits during the first several months after ... symptoms was showing promise; however, the April 1, 2014 ... Sung, Valerie) reported on a study, "Probiotics and Infant ... L reuteri for infant colic did not ...
(Date:4/17/2014)... potential to ward off depression among retirees, particularly among ... in The Journals of Gerontology, Series B: ... article " Internet Use and Depression Among Retired Older ... the authors report that Internet use reduced the probability ... study sample. , Late-life depression affects between 5 ...
Breaking Medicine News(10 mins):Health News:Chronic inflammation linked to 'high-grade' prostate cancer 2Health News:Chronic inflammation linked to 'high-grade' prostate cancer 3Health News:Live cell imaging reveals distinct alterations of subcellular glutathione potentials 2Health News:Building 'smart' cell-based therapies 2Health News:New study says probiotic use for infant colic is not effective in reducing symptoms 2Health News:Internet use may cut retirees' depression 2
... been found to reduce the risk of cellular ... top of standard immunosuppression. ,The drug, a ... receptor, thereby inhibiting T-cell proliferation. ,Patients who ... daclizumab or a placebo. ,The primary endpoint ...
... severe depression 'Transcranial Magnetic Stimulation' (TMS) maybe the ... the more aggressive electro-shock therapy., ,Electro-Shock Therapy or ... resort to treat severe depression for many decades. However, ... after therapy and requires general anesthesia. In ECT the ...
... people in the United States, Europe and Japan and many ... drinking calcium water may help in reducing osteoporosis., ,Calcium ... the people do not consume enough of this nutrient. ... osteoporosis but for many teenagers, and those in their twenties ...
... 598 068 nuclear industry workers from 15 countries.// The ... after administrating low doses of radiation. ,This study ... risk among radiation workers in the nuclear industry to ... dose exposure of radiation. ,The study recruits were ...
... time may be putting their health more at risk than ... that feeing angry for a very long time may cause ... pick up habits like smoking and drinking, or inducing stress ... of the literature that had tried to relate to various ...
... suffering from congenital central hypoventilation syndrome (CCHS) may suffer ... ,Congenital Central Hypoventilation Syndrome is the absence ... time. Children suffering from CCHS may not breathe regularly ... may be able to breathe during wakeful hours but ...
Cached Medicine News:Health News:Strong Magnetic Stimulation Can Help Treating Severe Depression 2Health News:Cancer risk among nuclear industry workers 2
(Date:1/15/2014)... THOUSAND OAKS, Calif. , Jan. 15, 2014 ... and Amgen (NASDAQ: AMGN ) announced ... to jointly discover and validate new therapeutic targets ... (IBD), a chronic disorder that affects millions worldwide. ...
(Date:1/15/2014)...  In an unprecedented effort to curb the spread of "superbugs" such ... vehicles, an advanced and portable UV germicidal lamp manufactured by MRSA-UV ... In order to prevent EMS paramedics and transport ... West Palm Beach Fire Rescue is the first in ...
(Date:1/15/2014)... 15, 2014  According to Millennium Research Group (MRG), ... the United States and ... will expand moderately through 2022, with embolization particles ... increasing interest in drug-eluting beads (DEBs) and radioembolization ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Frontage Laboratories, Inc., a ... US and China, and Spaulding Clinical Research, LLC, a ... Medical Device Manufacturer have entered into a strategic partnership ... footprint by combining Frontage,s presence in China and its ...
... SPRING, Md., Sept. 12, 2011 Today, the U.S. ... office responsible for reviewing all drug and biologic applications ... Research,s (CDER) Office of Oncology Drug Products has been ... Products (OHOP). (Logo: http://photos.prnewswire.com/prnh/20090824/FDALOGO) ...
Cached Medicine Technology:Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc. 2Spaulding Clinical Announces New Strategic Partnership With Frontage Laboratories, Inc. 3FDA Announces Changes in Drug Center's Oncology Office 2FDA Announces Changes in Drug Center's Oncology Office 3
Adhesive tape sheets for sealing multiwell plates and blocks;...
Microwell Plate Accessories...
DMSO-resistant microplate sealing film...
Amplification Tape 96 featuring 3M adhesive technology. Good optical quality. Minimal autofluorescence. Certified RNase and DNase free....
Medicine Products: